Cargando…
COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection
The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2 coronavirus started in March 2020. The conclusions from numerous studies indicate that people with comorbidities, such as arterial hypertension, diabetes, obesity, underlying cardiovascular disease, are particularly vul...
Autores principales: | Surma, Stanisław, Banach, Maciej, Lewek, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542506/ https://www.ncbi.nlm.nih.gov/pubmed/34689776 http://dx.doi.org/10.1186/s12944-021-01563-0 |
Ejemplares similares
-
A look to the past – what has had the biggest impact on lipids in the last four decades? A personal perspective
por: Banach, Maciej, et al.
Publicado: (2023) -
Targeted Treatment against Lipoprotein (a): The Coming Breakthrough in Lipid Lowering Therapy
por: Sosnowska, Bożena, et al.
Publicado: (2022) -
2023: The year in cardiovascular disease – the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024?
por: Banach, Maciej, et al.
Publicado: (2023) -
Fibrinogen and Atherosclerotic Cardiovascular Diseases—Review of the Literature and Clinical Studies
por: Surma, Stanisław, et al.
Publicado: (2021) -
Dietary salt intake and atherosclerosis: an area not fully explored
por: Banach, Maciej, et al.
Publicado: (2023)